BridgeBio's oral achondroplasia drug shows growth and body proportionality gains in late-stage trial
BridgeBio Pharma (BBIO) said its experimental oral drug for achondroplasia improved not only growth but also body proportionality in children with the condition, a secondary benefit that analysts believe could distinguish the treatment…